Creatine metabolism in urea cycle defects

Journal of Inherited Metabolic Disease

Volumn 35, Issue 4, 2012, Pages 647-653

  Boenzi, Sara ^a   Pastore, Anna ^a   Martinelli, Diego ^a   Goffredo, Bianca Maria ^a   Boiani, Arianna ^a   Rizzo, Cristiano ^a   Dionisi Vici, Carlo ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARYLBUTYRIC ACID DERIVATIVE; BENZOIC ACID; CITRULLINE; CREATINE; ESSENTIAL AMINO ACID;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ARGININOSUCCINIC ACIDURIA; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CITRULLINEMIA; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HYPERORNITHINEMIA HYPERAMMONEMIA HOMOCITRULLINURIA SYNDROME; INFANT; LYSINURIC PROTEIN INTOLERANCE; MALE; NEUROLOGIC DISEASE; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; PROTEIN RESTRICTION; REGULATORY MECHANISM; UREA CYCLE; UREA CYCLE DISORDER;

ADOLESCENT; ADULT; AMIDINOTRANSFERASES; ARGININE; CHILD; CHILD, PRESCHOOL; CREATINE; FEMALE; GUANIDINOACETATE N-METHYLTRANSFERASE; HUMANS; INFANT; LANGUAGE DEVELOPMENT DISORDERS; MALE; MOVEMENT DISORDERS; NERVE TISSUE PROTEINS; ORNITHINE-OXO-ACID TRANSAMINASE; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; UREA CYCLE DISORDERS, INBORN; YOUNG ADULT;

EID: 84863881422     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-012-9494-x     Document Type: Conference Paper

References (46)

1. Arias A, Garcia-Villoria J, Ribes A (2004) Guanidinoacetate and creatine/creatinine levels in controls and patients with urea cycle defects. Mol Genet Metab 82:220-223 (Pubitemid 38952655)
2. Barilli A, Rotoli BM, Visigalli R, Bussolati O, Gazzola GC, Gatti R, Dionisi-Vici C, Martinelli D, Goffredo BM, Font-Llitjós M, Mariani F, Luisetti M, Dall'asta V (2012) Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance. Mol Genet Metab 105(4):585-9
3. Béard E, Braissant O (2010) Synthesis and transport of creatine in the CNS: importance for cerebral functions. J Neurochem 115:297-313
4. Boenzi S, Rizzo C, Di Ciommo VM, Martinelli D, Goffredo BM, la Marca G, Dionisi-Vici C (2011) Simultaneous determination of creatine and guanidinoacetate in plasma by liquid chromatographytandem mass spectrometry (LC-MS/MS). J Pharm Biomed Anal 56:792-798
5. Braissant O, Henry H, Villard AM, Zurich MG, Loup M, Eilers B, Parlascino G, Matter E, Boulat O, Honegger P, Bachmann C (2002) Ammonium-induced impairment of axonal growth is prevented through glial creatine. J Neurosci 22:9810-9820 (Pubitemid 35332865)
6. Braissant O, Cagnon L, Monnet-Tschudi F, Speer O, Wallimann T, Honegger P, Henry H (2008) Ammonium alters creatine transport and synthesis in a 3D culture of developing brain cells, resulting in secondary cerebral creatine deficiency. Eur J Neurosci 27:1673-1685 (Pubitemid 351473571)
7. Braissant O, Henry H, Béard E, Uldry J (2011) Creatine deficiency syndromes and the importance of creatine synthesis in the brain. Amino Acids 40:1315-1324
8. Brosnan JT, Brosnan ME (2010) Creatine metabolism and urea cycle. Mol Genet Metab 100:49-52
9. Brosnan JT, da Silva RP, Brosnan ME (2007) Amino acids and the regulation of methyl balance in humans. Curr Opin Clin Nutr Metab Care 10:52-57 (Pubitemid 44901134)
10. Brosnan JT, da Silva RP, Brosnan ME (2011) The metabolic burden of creatine synthesis. Aminoacids 40:1325-1331
11. Brusilow SW, Batshaw ML (1979) Arginine therapy of argininosuccinase deficiency. Lancet 1:124-127 (Pubitemid 9104455)
12. Brusilow SW, Horwich AL (2001) Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly SW, Valle D (eds) The Metabolic and molecular bases of inherited diseasers.McGraw Hill, New York, pp 1909-1965
13. Choi CG, Yoo HV (2001) Localized proton MR spectroscopy in infants with urea cycle defect. Am J Neuroradiol 22: 834-837
14. Deignan JL, De Deyn PP, Cederbaum SD, Fuchshuber A, Roth B, Gsell W, Marescau B (2010) Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia. Mol Genet Metab 100:31-36
15. Dionisi Vici C, Bachmann C, Gambarara M, Colombo JP, Sabetta G (1987) Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: low creatine excretion and effect of citrulline, arginine, or ornithine supplement. Pediatr Res 22:364-367 (Pubitemid 17162805)
16. Erez A, Nagamani SC, Lee B (2011a) Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond. Am J Med Genet C Semin Med Genet 157:45-53
17. Erez A, Nagamani SC, Shchelochkov OA, Premkumar MH, Campeau PM, Chen Y, Garg HK, Li L, Mian A, Bertin TK, Black JO, Zeng H, Tang Y, Reddy AK, Summar M, O'Brien WE, Harrison DG, Mitch WE, Marini JC, Aschner JL, Bryan NS, Lee B (2011b) Requirement of argininosuccinate lyase for systemic nitric oxide production. Nat Med 17:1619-1626
18. Fons C, Sempere A, Arias A, López-Sala A, Póo P, Pineda M, Mas A, Vilaseca MA, Salomons GS, Ribes A, Artuch R, Campistol J (2008) Arginine supplementation in four patients with X-linked creatine transporter defect. J Inher Metab Dis 31:724-728
19. Gladwin MT, Tejero J (2011) Nitrite-NO bailout for a NOS complex too big to fail. Nat Med 17:1556-1557
20. Gropman AL, Fricke ST, Seltzer RR, Hailu A, Adeyemo A, Sawyer A, van Meter J, Gaillard WD, McCarter R, Tuchman M, Batshaw M, Urea Cycle Disorders Consortium (2008) 1H MRSidentifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency. Mol Genet Metab 95:21-30
21. Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Sanjurjo Crespo P, Santer R, Servais A, Valayannopoulos V, Lindner M, Rubio V, Dionisi-Vici C (2012) Guideline for the Diagnosis and management of urea cycle disorders. Orphanet J Rare Dis (in press)
22. Heinänen K, Näntö-Salonen K, Komu M, Erkintalo M, Alanen A, Heinonen OJ, Pulkki K, Nikoskelainen E, Sipilä I, Simell O (1999a) Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia. Eur J Clin Invest 29:1060-1065
23. Heinänen K, Näntö-Salonen K, Komu M, Erkintalo M, Heinonen OJ, Pulkki K, Valtonen M, Nikoskelainen E, Alanen A, Simell O (1999b) Muscle creatine phosphate in gyrate atrophy of the choroid and retina with hyperornithinaemia - clues to pathogenesis. Eur J Clin Invest 29:426-431 (Pubitemid 29211863)
24. Item CB, Stöckler-Ipsiroglu S, Stromberger C, Mühl A, Alessandrì MG, Bianchi MC, Tosetti M, Fornai F, Cioni G (2001) Arginine:glycine amidinotransferase (AGAT) deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 69:1127-1133 (Pubitemid 33015826)
25. Mannucci L, Emma F, Markert M, Bachmann C, Boulat O, Carrozzo R, Rizzoni G, Dionisi-Vici C (2005) Increased NO production in lysinuric protein intolerance. J Inherit Metab Dis 28:123-129 (Pubitemid 40723879)
26. Marescau B, Lowenthal A, Terheggen HG, Esmans E, Alderweireldt F (1982) Guanidino compounds in hyperargininemia. Adv Exp Med Biol 153:427-434
27. Martinelli D, Häberle J, Rubio V, Giunta C, Hausser I, Carrozzo R, Gougeard N, Marco-Marín C, Goffredo BM, Meschini MC, Bevivino E, Boenzi S, Colafati GS, Brancati F, Baumgartner MR, Dionisi-Vici C (2011) Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine. J Inherit Metab Dis [Epub ahead of print]
28. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012 (Pubitemid 24015045)
29. Morini C, Capozzi P, Boenzi S, Rizzo C, Santorelli FM, Dionisi-Vici C (2009) Retinal degeneration. Ophthalmology 116:1593-1593
30. Morris SM Jr (2006) Arginine: beyond protein. Am J Clin Nutr 83:508S-512S
31. Mudd SH, Brosnan JT, Brosnan ME, Jacobs RL, Stabler SP, Allen RH, Vance DE,Wagner C (2007) Methyl balance and transmethylation fluxes in humans. Am J Clin Nutr 85:19-25 (Pubitemid 46067610)
32. Nänto-Salonen K, Komu M, Lundbom N, Heinänen K, Alanen A, Sipilä I, Simell O (1999) Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology 53:303-307 (Pubitemid 29344351)
33. Ogier de Baulny H, Schiff M, Dionisi-Vici C (2012) Lysinuric protein intolerance (LPI): a multi organ disease by far more complex than a usual urea cycle disorder. Mol Genet Metab 106:12-17
34. Roze E, Azuar C, Menuel C, Häberle J, Guillevin R (2007) Usefulness of magnetic resonance spectroscopy in urea cycle disorders. Pediatr Neurol 37:222-225 (Pubitemid 47321058)
35. Salomons GS, van Dooren SJ, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, Jakobs C (2001) X-linked creatine transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 68:1497-1500 (Pubitemid 32510625)
36. Schulze A, Ebinger F, Rating D, Mayatepek E (2001) Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 74:413-419 (Pubitemid 34084650)
37. Sipilä I, Simell O, Arjomaa P (1980) Gyrate atrophy of the choroid and retina with hyperornithinemia. Deficient formation of guanidinoacetic acid from arginine. J Clin Invest 66:684-687 (Pubitemid 10060936)
38. Smith DW, Scriver CR, Tenenhouse HS, Simell O (1987) Lysinuric protein intolerance mutation is expressed in the plasma membrane of cultured skin fibroblasts. Proc Natl Acad Sci 84:7711-7715
39. Stockler S, Isbrandt D, Hanefeld F, Schmidt B, von Figura F (1996) Guanidinoacetate methyltransferse deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet 58:914-922 (Pubitemid 26115162)
40. Takanashi J, Kurihara A, Tomita M, Kanazawa M, Yamamoto S, Morita F, Ikehira H, Tanada S, Kohno Y (2002) Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency. Neurology 59:210-214 (Pubitemid 34779179)
41. Valayannopoulos V, Boddaert N, Mention K, Touati G, Barbier V, Chabli A, Sedel F, Kaplan J, Dufier JL, Seidenwurm D, Rabier D, Saudubray JM, de Lonlay P (2009) Secondary creatine deficiency in ornithine delta-amidinotransferase deficiency. Mol Genet Metab 97:109-113
42. Valayannopoulos V, Boddaert N, Chabli A, Barbier V, Desguerre I, Philippe A, Afenjar A, Mazzuca M, Cheillan D, Munnich A, de Keyzer Y, Jakobs C, Salomons GS, de Lonlay P (2012) Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J Inherit Metab Dis 35:151-157
43. van de Kamp JM, Pouwels PJ, Aarsen FK, ten Hoopen LW, Knol DL, de Klerk JB, de Coo IF, Huijmans JG, Jakobs C, van der Knaap MS, Salomons GS, Mancini GM (2012) Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect. J Inherit Metab Dis 35:141-149
44. van Spronsen FJ, Reijngoud DJ, Verhoeven NM, Soorani-Lunsing RJ, Jakobs C, Sijens PE (2006) High cerebral guanidinoacetate and variable creatine concentrations in argininosuccinate synthetase and lyase deficiency: implications for treatment? Mol Genet Metab 89:274-276 (Pubitemid 44468389)
45. Verhoeven NM, Salomons GS, Jakobs C (2005) Laboratory diagnosis of defects of creatine biosynthesis and transport. Clin Chim Acta 361:1-9 (Pubitemid 41382605)
46. Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80:1107-1213 (Pubitemid 30452013)